Cargando…
Chemotherapy regimens for metastatic nonsmall cell lung cancer: Generating good quality data is important before challenging evidence
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948249/ https://www.ncbi.nlm.nih.gov/pubmed/27578954 http://dx.doi.org/10.4103/0970-2113.184955 |
_version_ | 1782443301607047168 |
---|---|
author | Kaur, Harpreet Sehgal, Inderpaul Singh Singh, Navneet |
author_facet | Kaur, Harpreet Sehgal, Inderpaul Singh Singh, Navneet |
author_sort | Kaur, Harpreet |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4948249 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-49482492016-08-30 Chemotherapy regimens for metastatic nonsmall cell lung cancer: Generating good quality data is important before challenging evidence Kaur, Harpreet Sehgal, Inderpaul Singh Singh, Navneet Lung India Letters to Editor Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4948249/ /pubmed/27578954 http://dx.doi.org/10.4103/0970-2113.184955 Text en Copyright: © Indian Chest Society http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Letters to Editor Kaur, Harpreet Sehgal, Inderpaul Singh Singh, Navneet Chemotherapy regimens for metastatic nonsmall cell lung cancer: Generating good quality data is important before challenging evidence |
title | Chemotherapy regimens for metastatic nonsmall cell lung cancer: Generating good quality data is important before challenging evidence |
title_full | Chemotherapy regimens for metastatic nonsmall cell lung cancer: Generating good quality data is important before challenging evidence |
title_fullStr | Chemotherapy regimens for metastatic nonsmall cell lung cancer: Generating good quality data is important before challenging evidence |
title_full_unstemmed | Chemotherapy regimens for metastatic nonsmall cell lung cancer: Generating good quality data is important before challenging evidence |
title_short | Chemotherapy regimens for metastatic nonsmall cell lung cancer: Generating good quality data is important before challenging evidence |
title_sort | chemotherapy regimens for metastatic nonsmall cell lung cancer: generating good quality data is important before challenging evidence |
topic | Letters to Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948249/ https://www.ncbi.nlm.nih.gov/pubmed/27578954 http://dx.doi.org/10.4103/0970-2113.184955 |
work_keys_str_mv | AT kaurharpreet chemotherapyregimensformetastaticnonsmallcelllungcancergeneratinggoodqualitydataisimportantbeforechallengingevidence AT sehgalinderpaulsingh chemotherapyregimensformetastaticnonsmallcelllungcancergeneratinggoodqualitydataisimportantbeforechallengingevidence AT singhnavneet chemotherapyregimensformetastaticnonsmallcelllungcancergeneratinggoodqualitydataisimportantbeforechallengingevidence |